Performance of BGNE BeiGene | -39.8% in 12m
Compare BGNE with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare BeiGene with its related Sector/Index XBI
Performance Duell BGNE vs XBI
| TimeFrame | BGNE | XBI |
|---|---|---|
| 1 Day | 3.38% | 1.54% |
| 1 Week | 17.3% | -0.31% |
| 1 Month | -1.80% | -12.01% |
| 3 Months | -5.24% | -8.05% |
| 6 Months | -9.90% | 30.23% |
| 12 Months | -39.8% | 4.12% |
| YTD | -13.2% | -7.47% |
| Rel. Perf. 1m | 0.79 | |
| Rel. Perf. 3m | -2.24 | |
| Rel. Perf. 6m | -3.53 | |
| Rel. Perf. 12m | -5.77 |
Is BeiGene a good stock to buy?
No, based on ValueRay Fundamental Analyses, BeiGene (NASDAQ:BGNE) is currently (April 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -50.45 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BGNE as of April 2024 is 131.44. This means that BGNE is currently overvalued and has a potential downside of -14.42% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BGNE as of April 2024 is 131.44. This means that BGNE is currently overvalued and has a potential downside of -14.42% (Sold with Premium).
Is BGNE a buy, sell or hold?
- Strong Buy: 14
- Buy: 5
- Hold: 2
- Sell: 0
- Strong Sell: 0
Values above 0%: BGNE is performing better - Values below 0%: BGNE is underperforming
Compare BGNE with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 15.58% | 1.03% | -34.55% | -63.73% |
| US NASDAQ 100 | QQQ | 14.38% | 1.13% | -35.20% | -74.27% |
| US Dow Jones Industrial 30 | DIA | 17.31% | 2.03% | -28.93% | -54.03% |
| German DAX 40 | DBXD | 15.65% | 0.09% | -33.31% | -53.15% |
| UK FTSE 100 | ISFU | 14.80% | -2.83% | -26.21% | -46.21% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 15.84% | -3.67% | -11.80% | -25.88% |
| Hongkong Hang Seng | HSI | 10.69% | -4.57% | -7.37% | -19.68% |
| Japan Nikkei 225 | EXX7 | 17.60% | 6.41% | -26.84% | -57.33% |
| India NIFTY 50 | INDA | 16.46% | -3.22% | -31.69% | -67.24% |
| Brasil Bovespa | EWZ | 15.58% | 0.91% | -19.02% | -58.14% |
BGNE BeiGene vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 16.62% | 0.10% | -37.53% | -74.75% |
| Consumer Discretionary | XLY | 14.12% | 2.54% | -27.96% | -59.66% |
| Consumer Staples | XLP | 16.70% | -0.79% | -25.14% | -40.23% |
| Energy | XLE | 17.13% | -3.21% | -25.04% | -56.11% |
| Financial | XLF | 17.41% | 1.29% | -40.82% | -65.02% |
| Health Care | XLV | 16.95% | 3.46% | -24.48% | -46.30% |
| Industrial | XLI | 16.24% | 0.82% | -38.18% | -64.48% |
| Materials | XLB | 16.76% | 1.83% | -30.61% | -53.18% |
| Real Estate | XLRE | 16.49% | 5.97% | -24.58% | -39.79% |
| Technology | XLK | 14.42% | 2.25% | -34.40% | -73.32% |
| Utilities | XLU | 17.05% | -2.62% | -24.60% | -39.02% |
| Aerospace & Defense | XAR | 14.85% | 1.33% | -31.58% | -59.33% |
| Biotech | XBI | 17.60% | 10.21% | -40.13% | -43.88% |
| Homebuilder | XHB | 14.53% | 5.25% | -59.07% | -87.23% |
| Retail | XRT | 14.84% | 5.50% | -37.17% | -60.68% |
Does BeiGene outperform its market, is BGNE a Sector Leader?
No, over the last 12 months BeiGene (BGNE) made -39.76%, while its related Sector, the SPDR S&P Biotech (XBI) made 4.12%.
Over the last 3 months BGNE made -5.24%, while XBI made -8.05%.
No, over the last 12 months BeiGene (BGNE) made -39.76%, while its related Sector, the SPDR S&P Biotech (XBI) made 4.12%.
Over the last 3 months BGNE made -5.24%, while XBI made -8.05%.
| Period | BGNE | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -1.80% | -12.01% | -2.83% |
| 3 Months | -5.24% | -8.05% | 3.78% |
| 12 Months | -39.76% | 4.12% | 23.97% |